Moïse Namer
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 1%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Global Cancer Incidence and Screening
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 43
- Cancer Treatment and Pharmacology 27
- HER2/EGFR in Cancer Research 9
- Colorectal Cancer Treatments and Studies 6
-
- Breast Cancer Treatment Studies 23
- Co-authors
- M. Spielmann (10 shared papers)G. Milano (7 shared papers)P. Fumoleau (6 shared papers)Miguel Martín (2 shared papers)C.M. Lalanne (6 shared papers)Pierre Kerbrat (8 shared papers)M. Schneider (2 shared papers)A. Thyss (2 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Breast Cancer Research and Treatment (3 papers)Cancer (2 papers)Clinical Breast Cancer (2 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Moïse Namer
62 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 111
- Cancer Research 1.1k
- Oncology 1.8k
- Pathology and Forensic Medicine 326
- Genetics 496
- Pharmacology 113
Countries citing papers authored by Moïse Namer
This map shows the geographic impact of Moïse Namer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moïse Namer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moïse Namer more than expected).
Fields of papers citing papers by Moïse Namer
This network shows the impact of papers produced by Moïse Namer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moïse Namer. The network helps show where Moïse Namer may publish in the future.
Co-authors
The 25 scholars most cited alongside Moïse Namer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 465 | |
| 2 | 2004 | 278 | |
| 3 | 2005 | 205 | |
| 4 | 1986 | 186 | |
| 5 | 2001 | 122 | |
| 6 | 2004 | 113 | |
| 7 | 2007 | 102 | |
| 8 | Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer. | 1980 | 96 |
| 9 | 1993 | 93 | |
| 10 | 2010 | 92 | |
| 11 | 2004 | 82 | |
| 12 | 2003 | 80 | |
| 13 | 2006 | 78 | |
| 14 | 1996 | 69 | |
| 15 | 1987 | 62 | |
| 16 | 1992 | 57 | |
| 17 | 1991 | 50 | |
| 18 | 2001 | 44 | |
| 19 | 1989 | 40 | |
| 20 | 2009 | 36 |
About Moïse Namer
Moïse Namer is a scholar working on Oncology, Cancer Research, Genetics, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 62 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (27 papers), Breast Cancer Treatment Studies (23 papers), Estrogen and related hormone effects (11 papers), HER2/EGFR in Cancer Research (9 papers), Colorectal Cancer Treatments and Studies (6 papers), BRCA gene mutations in cancer (5 papers), Breast Lesions and Carcinomas (5 papers) and Chemotherapy-induced cardiotoxicity and mitigation (5 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.8k citations), Pathology and Forensic Medicine (326 citations), Genetics (496 citations) and Pharmacology (113 citations). Moïse Namer has collaborated with scholars based in France, United States and Italy. Frequent co-authors include M. Spielmann, G. Milano, P. Fumoleau, Miguel Martín, C.M. Lalanne, Pierre Kerbrat, M. Schneider, A. Thyss, Joyce O’Shaughnessy and Mei-Ching Liu. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Breast Cancer Research and Treatment, Cancer and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.